Skip to main navigation Skip to search Skip to main content

PhosphdiesteRasE-5 inhibition to improve CLinical status and EXercise capacity in diastolic heart failure (RELAX) trial: Rationale and design

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)653-659
Number of pages7
JournalCirculation: Heart Failure
Volume5
Issue number5
DOIs
StatePublished - Sep 2012

Keywords

  • Diastolic heart failure
  • Heart failure
  • Phosphodiesterase inhibitor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this